ClinicalTrials.govpublic full text
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
ovarian neoplasms, fallopian tube neoplasms, peritoneal neoplasms, ovarian cancer, fallopian tube cancer, primary peritoneal cancer, doxil, carboplatin, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 861801
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.